Kura: Transactions with Bristol Myers Squibb, Hercules Capital, Providing up to $150 M

  $25 million equity investment from Bristol Myers Squibb at $18.25 per share –

– Term loan facility from Hercules Capital provides up to $125 million –

– Proceeds extend Kura’s cash runway into 2026, if term loan is fully drawn –

https://finance.yahoo.com/news/kura-oncology-announces-financing-transactions-110000421.html